Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Solid Tumors, Neuroblastoma Drug Development

Patrick Reynolds

MD, PhD

🏢Texas Tech University Health Sciences Center🌐USA

Professor and Director, Cancer Center

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Patrick Reynolds directs the Children's Oncology Group neuroblastoma cell line and xenograft repository, enabling preclinical drug discovery. He has advanced fenretinide and retinoid-based approaches in minimal residual disease. His integrated preclinical-to-clinical pipeline has informed numerous neuroblastoma trials.

Share:

🧪Research Fields 研究领域

neuroblastoma cell lines
fenretinide
preclinical models
drug development pediatric
minimal residual disease

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Patrick Reynolds 的研究动态

Follow Patrick Reynolds's research updates

留下邮箱,当我们发布与 Patrick Reynolds(Texas Tech University Health Sciences Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment